[1]
G. Juan-Carpena, N. Martínez Banaclocha, J. C. Palazón Cabanes, M. Niveiro-de Jaime, I. Betlloch Mas, and M. Blanes-Martínez, “Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital”, Acta Derm Venereol, vol. 105, p. adv42023, Jan. 2025.